Clinical Trials Browser

Phase 2 × tozasertib × Clear all

NCT00290550 2015-07-27

A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00405054 2015-01-26

A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)

Phase 2 Terminated

Other hematologic neoplasm

Leukemia